ProfessorTimothy Hallett
Professor of Global Health
School of Public Health - Faculty of Medicine
Orcid identifier0000-0002-9681-0424 (opens in a new tab)
- Professor of Global HealthSchool of Public Health - Faculty of Medicine
- 020 7594 1150 (Work)
- School of Public Health, White City Campus, United Kingdom
RESEARCH
My work has focussed on using analytic methods to understand how resources can be used to maximise population health.
In early work in HIV, I showed how PrEP and ART can be used in tandem to the greatest effect [1] and how a spatial targeting of interventions can radically increase their efficiency [2], which fed into funding policy. I also developed several methods by which the HIV epidemic is monitored, which are adopted by WHO/UNAIDS [e.g., 3]. With the HIV Modelling Consortium, I led the critical evaluations of the expansion for criteria of ART [4-5] that fed into two rounds of WHO guidance updates.
I have also worked extensively in other fields of health, including HBV [6], HCV [7], where my work established the WHO and UN targets; and for HIV, TB and malaria [8], including my work with Global Fund to develop the ‘Investment Cases’ for each replenishment [9].
My interest in multi-disease interactions and patient-centred care began when I examined the build-up of comorbidities in persons living with HIV [10]. This led to further work in healthcare system modelling, where I have pioneered the development of the Thanzi La Onse Model [11], which has spurred many other analyses at the intersection of epidemiology, health-economics and system research.
My publications (>200 items) have attracted >24,000 citations and an h-index of 77.
Selected Publications
[1] Hallett, T. B., Baeten, J. M., Heffron, R., Barnabas, R., de Bruyn, G., Cremin, I., . . . Celum, C. (2011). Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling Study. PLOS MEDICINE, 8(11), 12 pages. doi:10.1371/journal.pmed.1001123
[2] Anderson, S. -J., Cherutich, P., Kilonzo, N., Cremin, I., Fecht, D., Kimanga, D., . . . Hallett, T. B. (2014). Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. LANCET,384(9939), 249-256. doi:10.1016/S0140-6736(14)61053-9
[3] Hallett, T. B., Zaba, B., Todd, J., Lopman, B., Mwita, W., Biraro, S., . . . Boerma, J. T. (2008). Estimating incidence from prevalence in generalised HIV epidemics: Methods and validation. PLOS MEDICINE, 5(4), 611-622. doi:10.1371/journal.pmed.0050080
[4] Eaton, J. W., Menzies, N. A., Stover, J., Cambiano, V., Chindelevitch, L., Cori, A., . . . Hallett, T. B. (2014). Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. LANCET GLOBAL HEALTH, 2(1), E23-E34. doi:10.1016/S2214-109X(13)70172-4
[5] Keebler, D., Revill, P., Braithwaite, S., Phillips, A., Blaser, N., Borquez, A., . . . Hallett, T. B. (2014). Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. LANCET GLOBAL HEALTH, 2(1), E35-E43. doi:10.1016/S2214-109X(13)70048-2
[6] Nayagam, S., Thursz, M., Sicuri, E., Conteh, L., Wiktor, S., Low-Beer, D., & Hallett, T. B. (2016). Requirements for global elimination of hepatitis B: a modelling study. LANCET INFECTIOUS DISEASES, 16(12), 1399-1408. doi:10.1016/S1473-3099(16)30204-3
[7] Heffernan, A., Cooke, G. S., Nayagam, S., Thursz, M., & Hallett, T. B. (2019). Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. LANCET, 393(10178), 1319-1329. doi:10.1016/S0140-6736(18)32277-3
[8] Hogan A, Jewell B, Sherrard-Smith E, Watson O, Whittaker C, Hamlet A, … , Hallett TB, 2020, Potential impact of the COVID-19 pandemic on HIV, TB and malaria in low- and middle-income countries: a modelling study, LANCET GLOBAL HEALTH (8):e1132-e1141, ISSN: 2214-109X DOI: 10.1016/S2352-3018(20)30211-3
[9] Hallett TB, Menzies NA, Resch S, et al. The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study. The Lancet 2025; 0. DOI:10.1016/S0140-6736(25)00831-1.
[10] Smit, M., Brinkman, K., Geerlings, S., Smit, C., Thyagarajan, K., van Sighem, A., . . . Hallett, T. B. (2015). Future challenges for clinical care of an ageing population infected with HIV: a modelling study. LANCET INFECTIOUS DISEASES, 15(7), 810-818. doi:10.1016/S1473-3099(15)00056-0
[11] Hallett TB, Mangal TD, Tamuri AU, Arinaminpathy N, Cambiano V, Chalkley M, et al. (2024) Estimates of resource use in the public-sector health-care system and the effect of strengthening health-care services in Malawi during 2015–19: a modelling study (Thanzi La Onse). The Lancet Global Health. doi:10.1016/S2214-109X(24)00413-3.
In early work in HIV, I showed how PrEP and ART can be used in tandem to the greatest effect [1] and how a spatial targeting of interventions can radically increase their efficiency [2], which fed into funding policy. I also developed several methods by which the HIV epidemic is monitored, which are adopted by WHO/UNAIDS [e.g., 3]. With the HIV Modelling Consortium, I led the critical evaluations of the expansion for criteria of ART [4-5] that fed into two rounds of WHO guidance updates.
I have also worked extensively in other fields of health, including HBV [6], HCV [7], where my work established the WHO and UN targets; and for HIV, TB and malaria [8], including my work with Global Fund to develop the ‘Investment Cases’ for each replenishment [9].
My interest in multi-disease interactions and patient-centred care began when I examined the build-up of comorbidities in persons living with HIV [10]. This led to further work in healthcare system modelling, where I have pioneered the development of the Thanzi La Onse Model [11], which has spurred many other analyses at the intersection of epidemiology, health-economics and system research.
My publications (>200 items) have attracted >24,000 citations and an h-index of 77.
Selected Publications
[1] Hallett, T. B., Baeten, J. M., Heffron, R., Barnabas, R., de Bruyn, G., Cremin, I., . . . Celum, C. (2011). Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling Study. PLOS MEDICINE, 8(11), 12 pages. doi:10.1371/journal.pmed.1001123
[2] Anderson, S. -J., Cherutich, P., Kilonzo, N., Cremin, I., Fecht, D., Kimanga, D., . . . Hallett, T. B. (2014). Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. LANCET,384(9939), 249-256. doi:10.1016/S0140-6736(14)61053-9
[3] Hallett, T. B., Zaba, B., Todd, J., Lopman, B., Mwita, W., Biraro, S., . . . Boerma, J. T. (2008). Estimating incidence from prevalence in generalised HIV epidemics: Methods and validation. PLOS MEDICINE, 5(4), 611-622. doi:10.1371/journal.pmed.0050080
[4] Eaton, J. W., Menzies, N. A., Stover, J., Cambiano, V., Chindelevitch, L., Cori, A., . . . Hallett, T. B. (2014). Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. LANCET GLOBAL HEALTH, 2(1), E23-E34. doi:10.1016/S2214-109X(13)70172-4
[5] Keebler, D., Revill, P., Braithwaite, S., Phillips, A., Blaser, N., Borquez, A., . . . Hallett, T. B. (2014). Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. LANCET GLOBAL HEALTH, 2(1), E35-E43. doi:10.1016/S2214-109X(13)70048-2
[6] Nayagam, S., Thursz, M., Sicuri, E., Conteh, L., Wiktor, S., Low-Beer, D., & Hallett, T. B. (2016). Requirements for global elimination of hepatitis B: a modelling study. LANCET INFECTIOUS DISEASES, 16(12), 1399-1408. doi:10.1016/S1473-3099(16)30204-3
[7] Heffernan, A., Cooke, G. S., Nayagam, S., Thursz, M., & Hallett, T. B. (2019). Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. LANCET, 393(10178), 1319-1329. doi:10.1016/S0140-6736(18)32277-3
[8] Hogan A, Jewell B, Sherrard-Smith E, Watson O, Whittaker C, Hamlet A, … , Hallett TB, 2020, Potential impact of the COVID-19 pandemic on HIV, TB and malaria in low- and middle-income countries: a modelling study, LANCET GLOBAL HEALTH (8):e1132-e1141, ISSN: 2214-109X DOI: 10.1016/S2352-3018(20)30211-3
[9] Hallett TB, Menzies NA, Resch S, et al. The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study. The Lancet 2025; 0. DOI:10.1016/S0140-6736(25)00831-1.
[10] Smit, M., Brinkman, K., Geerlings, S., Smit, C., Thyagarajan, K., van Sighem, A., . . . Hallett, T. B. (2015). Future challenges for clinical care of an ageing population infected with HIV: a modelling study. LANCET INFECTIOUS DISEASES, 15(7), 810-818. doi:10.1016/S1473-3099(15)00056-0
[11] Hallett TB, Mangal TD, Tamuri AU, Arinaminpathy N, Cambiano V, Chalkley M, et al. (2024) Estimates of resource use in the public-sector health-care system and the effect of strengthening health-care services in Malawi during 2015–19: a modelling study (Thanzi La Onse). The Lancet Global Health. doi:10.1016/S2214-109X(24)00413-3.
GRANTS
- GRANTMRC Centre for Outbreak Analysis and Modelling (Renewal P07082)Medical Research Council (MRC)1 Apr 2013 - 31 Mar 2018